- Home
- PBK vs LTRN Comparison
PBK vs LTRN Comparison
Compare PBK & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBK | LTRN |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 27.6M |
| IPO Year | 2024 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PBK | LTRN |
|---|---|---|
| Price | $0.34 | $1.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 731.9K | 143.7K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $1.11 |
| 52 Week High | $0.86 | $4.70 |
Technical Indicators
Market Signals| Indicator | PBK | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 23.43 | 21.29 |
| Support Level | N/A | $1.11 |
| Resistance Level | $0.50 | $3.01 |
| Average True Range (ATR) | 0.03 | 0.17 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 2.42 | 5.80 |
Price Performance
Historical ComparisonAbout PBK PowerBank Corporation Common Stock
PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.